Digoxin is a cardiac glycoside used to manage certain heart conditions. It is available as a generic medication and marketed under brand names such as Lanoxin and Digitek. In Hong Kong, digoxin is classified as a prescription-only medicine and is regulated by the Department of Health’s Pharmacy and Poisons Board. The medication is supplied as a 0.25 mg oral pill.
Digoxin exerts its therapeutic effect by inhibiting the sodium-potassium ATP-pump in cardiac myocytes. This inhibition leads to an increase in intracellular sodium, which in turn reduces the activity of the sodium-calcium exchanger. The result is a higher intracellular calcium concentration, enhancing the contractile force of the heart (positive inotropy).
In addition to its inotropic action, digoxin stimulates the vagus nerve, producing a modest slowing of atrial conduction and a reduction in ventricular rate during atrial fibrillation. Onset of action after oral administration typically occurs within 30 minutes to 2 hours, with peak plasma concentrations reached in 2 hours. The drug’s elimination half-life ranges from 36 to 48 hours in patients with normal renal function, and it is primarily excreted unchanged by the kidneys.
Digoxin is approved for the following indications in Hong Kong and many other jurisdictions:
These approvals are based on regulatory evaluations by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), both of which recognize digoxin’s role in the above conditions.
Supraventricular tachycardia (SVT) Some clinicians have employed digoxin off-label for certain SVT episodes, but evidence is limited and the practice requires careful monitoring.
Pulmonary hypertension Small case series have explored digoxin’s potential benefit in right-ventricular failure secondary to pulmonary hypertension. Use in this setting remains investigational and should only occur under specialist supervision.
Off-label use requires medical supervision and individualized risk assessment.
These effects are usually mild and may resolve with dose adjustment.
Immediate medical attention is required if any of these symptoms occur.
Patients should provide a complete medication list-including over-the-counter products and herbal supplements-to their healthcare provider before initiating digoxin.
Regular follow-up visits every 1-3 months are common during initial titration, after which intervals may be extended if the patient remains stable.
This article provides educational information about digoxin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, digoxin is often prescribed together with beta-blockers to achieve complementary rate control in atrial fibrillation. However, the combination can increase the risk of bradycardia, so dose adjustments and close monitoring are advisable.
Visual disturbances such as a yellow-green halo are classic signs of digoxin toxicity. Contact your healthcare provider promptly for evaluation and possible serum level testing.
Both generic and brand-name formulations contain the same active ingredient, digoxin, and must meet identical quality standards. Inactive ingredients may differ slightly, which can affect tolerability in a small number of patients.
Steady-state concentrations are usually achieved after 6-7 days of consistent dosing, given the drug’s half-life of about 36-48 hours in individuals with normal renal function.
Yes, but you should carry the original prescription label, a copy of the prescribing doctor’s note, and keep the medication in its original container. Some countries may require additional documentation for controlled substances.
High-fiber meals can modestly reduce digoxin absorption, while large amounts of caffeine may increase heart rate. Maintaining a consistent diet helps keep drug levels stable.
Hypokalemia enhances digoxin’s binding to the sodium-potassium pump, raising the risk of toxicity. It is important to correct low potassium levels before or during digoxin treatment.
Routine serum digoxin monitoring is recommended after dose initiation, after any dose change, and periodically thereafter, especially in patients with renal impairment or concurrent interacting medicines.
Do not flush digoxin tablets down the toilet. Return unused or expired medication to a pharmacy’s take-back program or follow local hazardous-waste disposal guidelines to prevent accidental ingestion.
